What the Research Found

A comprehensive study published in the journal Healthcare tracked how Medicaid expansion affected access to focus-supporting approaches for children across multiple years. The analysis compared states that expanded Medicaid eligibility with those that did not.

Before the COVID-19 pandemic, expansion states showed lower overall odds of children using ADHD-related medication approaches (adjusted odds ratio of 0.68). This suggested that when families had better access to healthcare coverage, they pursued more comprehensive support options beyond medication alone.

Then came the pandemic. During COVID-19 disruptions, the pattern flipped entirely—expansion states now showed higher odds of medication use (adjusted odds ratio of 1.35). Researchers concluded this indicated stabilization of access amid the chaos, meaning families in expansion states could maintain their children’s support even when everything else was disrupted.